Triple
T4655923
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Graduate School of Frontier Biosciences |
E102407
|
entity |
| Predicate | field |
P3
|
FINISHED |
| Object |
frontier biosciences
Frontier biosciences is an interdisciplinary scientific field that explores the fundamental principles and emerging frontiers of life sciences, often integrating biology with physics, chemistry, engineering, and computational approaches.
|
E207771
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: frontier biosciences | Statement: [Graduate School of Frontier Biosciences, field, frontier biosciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: frontier biosciences Context triple: [Graduate School of Frontier Biosciences, field, frontier biosciences]
-
A.
Frontier Research Institute for Interdisciplinary Sciences
The Frontier Research Institute for Interdisciplinary Sciences is a research center at Tohoku University that promotes cutting-edge, cross-disciplinary scientific collaboration across diverse fields.
-
B.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
C.
BioFrontiers Institute
BioFrontiers Institute is an interdisciplinary research center at the University of Colorado Boulder focused on advancing bioscience and biotechnology through collaborative innovation.
-
D.
H3 Biomedicine
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
-
E.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: frontier biosciences Triple: [Graduate School of Frontier Biosciences, field, frontier biosciences]
Generated description
Frontier biosciences is an interdisciplinary scientific field that explores the fundamental principles and emerging frontiers of life sciences, often integrating biology with physics, chemistry, engineering, and computational approaches.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: frontier biosciences Target entity description: Frontier biosciences is an interdisciplinary scientific field that explores the fundamental principles and emerging frontiers of life sciences, often integrating biology with physics, chemistry, engineering, and computational approaches.
-
A.
Frontier Research Institute for Interdisciplinary Sciences
The Frontier Research Institute for Interdisciplinary Sciences is a research center at Tohoku University that promotes cutting-edge, cross-disciplinary scientific collaboration across diverse fields.
-
B.
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
C.
BioFrontiers Institute
chosen
BioFrontiers Institute is an interdisciplinary research center at the University of Colorado Boulder focused on advancing bioscience and biotechnology through collaborative innovation.
-
D.
H3 Biomedicine
H3 Biomedicine is a biotechnology company focused on discovering and developing precision cancer therapies using genomics-driven approaches.
-
E.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43d823288190952279faa0d1d066 |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd63193a108190a7d9aec1d1d40cf8 |
completed | March 20, 2026, 3:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bdfaf28c148190b46cf846528034c5 |
completed | March 21, 2026, 1:57 a.m. |
| NEDg | Description generation | batch_69bdfc6751988190917ec53a8e2e27ec |
completed | March 21, 2026, 2:03 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69be009e6c488190b18e1b2b4b34ecef |
completed | March 21, 2026, 2:21 a.m. |
Created at: March 20, 2026, 1:14 p.m.